Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.3
Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Current assets:    
Cash and cash equivalents $ 4,301,000 $ 22,676,000
Restricted cash 3,025,000  
Investments in debt securities   10,845,000
Accounts receivable - trade   1,000,000
Subscription receivable 204,000  
Settlement receivable - current portion   5,100,000
Prepaid expenses and other current assets 664,000 1,549,000
Current assets held for sale 18,065,000 3,900,000
Total Current Assets 26,259,000 45,070,000
Restricted cash 253,000 5,996,000
Promissory note receivable and accrued interest 1,706,000 1,631,000
Finance lease right-of-use assets, net of accumulated amortization 610,000  
Operating lease right-of-use asset 2,722,000 3,068,000
Fixed assets, net of accumulated depreciation 4,219,000 1,373,000
Intangible assets, net of accumulated amortization 5,388,000 4,851,000
Security deposits 50,000 29,000
Prepaid expenses - noncurrent   74,000
Noncurrent assets held for sale   37,314,000
Total Assets 41,207,000 99,406,000
Current liabilities:    
Accounts payable 1,849,000 4,264,000
Accrued expenses 4,034,000 3,764,000
Finance lease obligations - current portion 272,000  
Operating lease obligation - current portion 389,000 91,000
Equipment financing payable - current portion 160,000  
Term note payable - net of deferred financing costs 12,937,000 22,161,000
Contract liabilities 0 100,000
Current liabilities related to assets held for sale 1,941,000 56,000
Total Current Liabilities 21,582,000 30,436,000
Finance lease obligations - net of current portion 351,000  
Operating lease obligation - net of current portion 3,125,000 3,514,000
Equipment financing payable - net of current portion 241,000  
Accrued expenses - noncurrent 527,000  
Noncurrent liabilities related to assets held for sale   1,971,000
Total Liabilities 25,826,000 35,921,000
Stockholders' Equity    
Series 2022 Convertible Preferred Stock - $0.001 par value; 1,000,000 shares authorized; 0 and 1,000 shares issued and outstanding as of June 30, 2023 and 2022
Common Stock - $0.001 par value; 275,000,000 shares authorized at June 30, 2023 and 2022; 20,310,077 and 8,727,158 shares issued and outstanding as of June 30, 2023 and June 30, 2022, respectively 20,000 9,000
Additional paid-in capital 304,301,000 287,619,000
Accumulated other comprehensive loss   (213,000)
Accumulated deficit (288,940,000) (223,930,000)
Total Stockholders' Equity 15,381,000 63,485,000
Total Liabilities and Stockholders' Equity $ 41,207,000 $ 99,406,000